澳州昆士兰大学2018年招聘博士后（分子生物学）

INSTITUTE FOR MOLECULAR BIOSCIENCE

The University of Queensland’s Institute for Molecular Bioscience (IMB) is a leading global life sciences research institute committed to improving quality of life through research. IMB was established in 2000 as UQ’s first research institute and is the cornerstone of one of the largest bioscience research precincts in Australia.

The Institute is home to more than 450 researchers, postgraduate students and support staff from more than 40 countries who work in partnership with their academic, industry and clinical colleagues around the world to advance knowledge in areas including pain, rare diseases, inflammation, superbug infection, cardiovascular disease, environmental research, drug discovery and development, cancer, diabetes and obesity, and reproductive health. Our mission is to drive the bioeconomy and create better health; our vision is to be a life sciences institute with global impact.

Details of the research interests of the Institute may be accessed on the Institute’s website at https://imb.uq.edu.au/

The Institute recognises and values equity and diversity, and encourages applications from any individual who meets the requirements of this position irrespective of gender, sexuality, race, ethnicity, religion, disability, age or other protected attributes.

IMB strives to provide an inclusive working environment, and along with the University is committed to supporting staff with family and caring responsibilities by providing policies, programs and initiatives to help balance work and family responsibilities.

Specific initiatives at IMB can be found at (https://imb.uq.edu.au/about/equity-and-diversity-imb)

The role: Two positions are available. The successful appointee(s) will join an exciting project characterising the ‘inflammasome’ pathway that mediates immune system activation during infection, injury and inflammatory and neurodegenerative diseases. The successful appointee(s) will have the opportunity to develop their research career(s) in a laboratory with a strong emphasis on training and mentorship, within a multidisciplinary research environment. There will be opportunities to for the successful appointee(s) to supervise postgraduate students and to apply for their own research funding. For more information about the lab’s research, see https://imb.uq.edu.au/inflammasomes.

The person: Applicants should possess a PhD and a strong track record in innate immunity, inflammation, cell death, or host-pathogen interactions. A broad skill base, including molecular and cellular biology, biochemistry, immunological assays and in vivo murine modles is highly desirable. Applicants should possess a strong desire to develop a successful and highly-productive research career in immunological research, excellent general research skills, a strong methodological background, excellent writing abilities, and the capacity to work both independently and within a team.

The University of Queensland values diversity and inclusion and actively encourages applications from those who bring diversity to the University. Please refer to the University’s Diversity and Inclusion webpage (https://staff.uq.edu.au/information-and-services/human-resources/diversity) for further information and points of contact if you require additional support.

This role is a full-time position; however flexible working arrangements may be negotiated.

Remuneration: This is a full-time, fixed-term appointment for one year at Academic Level A. The remuneration package will be in the range AUD$77,307 – $89,285 p.a., plus employer superannuation contributions of up to 17% (total package will be in the range AUD$90,449 – $104,464 p.a.).

Enquiries: To discuss this role please contact Associate Professor Kate Schroder via email K.Schroder@uq.edu.au. To submit an application for this role, go to http://jobs.uq.edu.au/caw/en/job/505573/postdoctoral-research-fellow and use the Apply button. All applicants must supply the following documents: Cover letter, Resume and Selection Criteria responses.

Applications close: 3 January 2019